COVID-19 and investment
Despite testing economic conditions, many companies are still looking for opportunities to invest and grow.
While the economic impact of COVID-19 is significant and still unfolding, moves have been made to give companies confidence to continue with plans to invest. These include temporary measures by the Australian Securities Exchange to facilitate capital raising and changes to the foreign investment review framework designed to protect the national interest.
M&A due diligence in the time of COVID-19: What are the ‘hangover’ risks in corporate transactions?
M&A activity continues despite COVID-19, and the changing circumstances may be providing opportunities for buyers. However, measures taken to keep businesses alive during this time may leave you with a nasty hangover post-acquisition.
ASX and ASIC introduce new temporary rules to facilitate capital raising
The Australian Securities Exchange has recently introduced temporary changes to its rules to facilitate emergency capital raisings against the current backdrop of the COVID-19 pandemic. Our Equity Capital Markets team outlines the changes.
Foreign Investment Review Board – Response to COVID-19
The Treasurer of Australia, The Hon Josh Frydenberg MP, announced on 29 March 2020 temporary changes to the foreign investment review framework, designed to protect Australia’s national interest.
Foreign Investment Review Board (FIRB) – COVID-19 changes and impact on capital raising and M&A
The Commonwealth Government announced temporary changes to the foreign investment review framework, designed to protect Australia’s national interest during the COVID-19 crisis. Whilst these temporary measures are in place, Australian companies (particularly small cap companies) looking to firm up additional funding from foreign investors or vendors seeking to sell Australian businesses or companies to foreign investors, are now more likely to require FIRB approval before these investments or acquisitions can take place.
Year-end earnings surprises and continuous disclosure: COVID-19 impact
With the financial year end (or half year) looming for many companies and the impact of COVID-19 over the last few months becoming clearer, ASX listed companies need to think carefully about their market disclosure obligations.
Looking out for smaller businesses – the revised rules for Commonwealth Procurement
We explain the effect of recently enacted changes to the Commonwealth Procurement Rules, which commence on 1 July 2022.
Australian Contract Law: a recent case study – Sui v Jiang  NSWCA 285
Lost in translation: when the legal effect of a contract departs from its literal meaning...
Former Minister Hunt’s final address at the Australian Pharmacy Professional Conference 2022 and PBS changes
We discuss former Minister Greg Hunt’s address at this year's APP Conference.